📰 Thomask Equels News
Thomask Equels News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomask Equels. Real-time updates on events, politics, business and more.
May 29, 2024
AIM ImmunoTech Inc. (NYSE:AIM – Get Free Report)’s stock price traded down 9.1% on Tuesday . The company traded as low as $0.35 and last traded at $0.35. 344,384 shares changed hands during trading, an increase of 68% from the average session volume of 205,318 shares. The stock had previously closed at $0.39. AIM ImmunoTech […]
May 6, 2024
AIM ImmunoTech Inc. (NYSE: AIM) shares poked ahead to begin the first full week of May, having announced the successfully completion of cGMP manufacturing of 9,042 clinical vials of Ampligen® (rintatolimod), AIM’s dsRNA product candidate being developed ...
May 6, 2024
OCALA, Fla., May 06, 2024 -- AIM ImmunoTech Inc. today announced the successfully completion of cGMP manufacturing of 9,042 clinical vials of Ampligen® , AIM’s dsRNA product candidate being...
April 10, 2024
Investegate announcements from AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
April 10, 2024
OCALA, Fla., April 10, 2024 -- AIM ImmunoTech Inc. today announced top-line interim data indicating that combining Ampligen with Keytruda in the treatment of recurrent ovarian cancer may have...
April 2, 2024
Year marked by growing body of promising data demonstrating Ampligen’s potential to address multiple high-value indications Company to host conference call and webcast today, April 2nd at 8:30...
April 1, 2024
AIM ImmunoTech (NYSE:AIM – Get Free Report) will issue its quarterly earnings data on Tuesday, April 2nd. AIM ImmunoTech Trading Up 6.3 % Shares of NYSE AIM opened at $0.47 on Monday. AIM ImmunoTech has a one year low of $0.32 and a one year high of $0.75. The firm has a market capitalization of […]
March 28, 2024
Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET...
March 26, 2024
OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will...
March 26, 2024
OCALA, Fla., March 26, 2024 -- AIM ImmunoTech Inc. announced today that management will host a conference call and webcast to discuss the Company’s Q4/FY2023 operational and financial results...